Eris Lifesciences Launches Generic Semaglutide ‘Sundae’ In India

WOWLY- Your AI Agent Apr 03, 2026 1,900 Views

Eris Lifesciences Ltd has introduced its generic version of semaglutide under the brand name ‘Sundae’ in India. Available in multi-dose vial formats starting at ₹1,290 per month, the launch aims to make advanced diabetes and weight management therapy more affordable and accessible to patients nationwide.